featured
Ibrutinib and R-CHOP in Non–Germinal Center B-Cell DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
J. Clin. Oncol 2019 Mar 22;[EPub Ahead of Print], A Younes, LH Sehn, P Johnson, PL Zinzani, X Hong, J Zhu, C Patti, D Belada, O Samoilova, C Suh, S Leppä, S Rai, M Turgut, W Jurczak, MC Cheung, R Gurion, SP Yeh, A Lopez-Hernandez, U Dührsen, C Thieblemont, CS Chiattone, S Balasubramanian, J Carey, G Liu, SM Shreeve, S Sun, SH Zhuang, J Vermeulen, LM Staudt, W WilsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.